X

On July 3, 2020 Sanofi Genzyme was notified that our Lemtrada Home Phlebotomy Partner, Examination Management Services Inc., (EMSI) has gone out of business. Because of this, unfortunately, all future Lemtrada Home Phlebotomy (lab draw) visits from EMSI have been cancelled. Patient safety is Sanofi Genzyme’s #1 priority and we are working to provide an alternative phlebotomy solution as well as coordinate alternative testing options for your next monthly lab tests. If you have any questions related to this announcement, please contact your healthcare provider or your One to One Nurse at 1-855-557-2483.

MAT-US-2015317

LEMTRADA is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include relapsing-remitting disease and active secondary progressive disease, in adults. Since treatment with LEMTRADA can increase your risk of getting certain conditions and diseases, LEMTRADA is generally prescribed for people who have tried 2 or more MS medicines that have not worked well enough. LEMTRADA is not recommended for use in patients with clinically isolated syndrome (CIS). It is not known if LEMTRADA is safe and effective for use in children under 17 years of age.

LEMTRADA is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include relapsing-remitting disease and active secondary progressive disease, in adults. Since treatment with LEMTRADA can increase your risk of getting certain conditions and diseases, LEMTRADA is generally prescribed for people who have tried 2 or more MS medicines that have not worked well enough. LEMTRADA is not recommended for use in patients with clinically isolated syndrome (CIS). It is not known if LEMTRADA is safe and effective for use in children under 17 years of age.

LEMTRADA EXPERIENCES
CLICK TO SWITCH

FIND OUT WHAT TO EXPECT WHEN YOU START LEMTRADA TREATMENT FOR RELAPSING MS

An article written by a LEMTRADA patient sharing how he makes a commitment to monitoring

MONTHLY MONITORING WITH LEMTRADA

By Donnie, Father, Husband, Project Leader, Former Athlete

No matter what relapsing MS treatment you choose, you’re making a commitment. And LEMTRADA is no different. It’s like being in a committed relationship. You have to do your part to make it work. One of the additional commitments you have to make with LEMTRADA is to complete monthly monitoring for potential autoimmune side effects.

Monitoring consists of monthly blood and urine tests, as well as annual skin checks (and self checks)—and this happens after your first treatment course and for 4 years or longer after your last round of treatment. Monitoring is a very important commitment.

One thing I was glad about is that I had a say in where and when my labs were completed. There are a few monitoring options to choose from. I could travel to a local facility each month or I could have them come to me. I choose to have the lab technician come to my house and it has worked out great. I found I have been able to fit it into my busy schedule.

So, at the beginning of each month the lab tech sends me a text asking about my availability. We agree on the date and time—and that’s it! I work full-time outside the home, so I leave work (only 15 minutes from home) and meet the tech at my house—then before I know it, I’m on my way back to work.

Another plus is that I have developed a pretty good friendship with the lab tech. She knows my wife and kids by name, so she has become part of my LEMTRADA family, as I like to call it. My dog even likes her, which is very unusual.

On top of all that, I also receive follow-up calls from my MS One to One nurse to make sure that everything is going well. These calls and the monthly monitoring are reassuring because I know someone else is looking out for me on my LEMTRADA treatment journey.

TAP TO SWITCH
Important Safety Information See More

LEMTRADA can cause serious side effects including serious autoimmune problems. Some people receiving LEMTRADA develop a condition where the immune cells in your body attack other cells or organs in the body (autoimmunity), which can be serious and may cause death. Serious autoimmune problems may include: